Branched Poly(β-Amino Ester) Vectors for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing polymer-based vectors for nucleic acid delivery suffer from limited transfection efficiency and toxicity, necessitating the development of improved polymer-based vectors with enhanced delivery capabilities.
Innovation Solution
The development of branched poly(-amino ester) polymers connected via branched linkers, which are designed to improve the delivery of nucleic acids into cells by enhancing transfection efficiency and biocompatibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If polymer-based vectors are used for nucleic acid delivery, then transfection efficiency is improved, but toxicity increases
Solution Approach 1:
The patent modifies the chemical structure of poly(β-amino ester) polymers by changing parameters such as incorporating cyclic carbonate units, varying the ratio of amino monomers to hydroxyl monomers, and adjusting molecular weight. These parameter changes optimize the balance between transfection efficiency and cellular toxicity, achieving improved delivery while reducing harmful effects.
Solution Approach 2:
The patent creates composite polymer structures by combining multiple monomer types (amino monomers, hydroxyl monomers, and cyclic carbonate units) within a single polymer vector. This composite approach allows the vector to simultaneously achieve high transfection efficiency through amino group interactions with nucleic acids while the hydroxyl and carbonate components reduce toxicity and improve biocompatibility.
2Duration of action of stationary object
If linear poly(β-amino ester) polymers are used, then biodegradability is improved, but transfection efficiency is limited
Solution Approach 1:
The patent develops composite polymer structures combining linear poly(β-amino ester) segments with cyclic carbonate units and hydroxyl-containing monomers. This composite design maintains the biodegradability of linear PBAEs while the additional components enhance transfection efficiency through improved cellular uptake and nucleic acid complexation capabilities.
Solution Approach 2:
The patent modifies the molecular structure parameters of linear PBAEs by incorporating cyclic carbonate units at specific positions and adjusting the ratio of amino to hydroxyl monomers. These parameter changes enable the polymer to maintain biodegradability while significantly improving transfection efficiency through enhanced cellular interaction and nucleic acid delivery.
3Ease of manufacture
If polymer structure is simplified for easier synthesis, then ease of manufacture is improved, but delivery performance deteriorates
Solution Approach 1:
The patent divides the polymer synthesis into sequential steps: first forming linear poly(β-amino ester) segments through standard condensation reactions, then incorporating cyclic carbonate units and hydroxyl-containing monomers in subsequent steps. This segmentation allows each step to be optimized for ease of synthesis while the cumulative structure achieves superior delivery performance.
Solution Approach 2:
The patent employs controlled parameter changes during synthesis, such as adjusting monomer ratios, reaction temperatures, and catalyst concentrations, to achieve the desired polymer architecture. These controlled parameter modifications enable the synthesis of complex multi-component polymers while maintaining practical manufacturability through established chemical methods.
Data Source
AI summary
The present disclosure provides branched poly(β-amino esters) (PBAEs) of Formula (I) made by reacting primary amines with diacrylates. Further provided herein are compositions comprising the polymers of Formula (I), and methods of using the compositions and polymers as described herein for the treatment of disease.L-(R)n (I)